GUARD-AKI: Validation of AKI-Sapere in Cardiac Surgery Patients
Completed
Conditions studied: Coronary Artery Disease
In brief
Cardiac surgery associated acute kidney injury (CSA-AKI) has been recognized as the second most common cause of hospital acquired AKI. The development of CSA-AKI is independently associated with an increased risk of in-hospital death. There are currently no biomarkers that could identify patients at higher risk for AKI and current risk predictor scores that are based on clinical and demographic information are inadequate. Therefore, a diagnostic test for predicting AKI risk in this clinical context would assist clinicians to optimize surgical strategy and postoperative care to prevent CSA-AKI occurrence and improve patient outcomes. The primary purpose of this study is to validate a panel of biomarkers identified in the discovery study (referred to as AKI-Sapere prognostic) to identify patients at risk for all stages of CSA-AKI.
Key facts
- Study ID
- NCT03635606
- Run by
- Sapere Bio
- People needed
- 370
- Starts
- 2020-02-24
- Expected to finish
- 2023-02-28
- Last updated by the study team
- 2023-04-04
Who can join
Age: 40 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult patients (>40 years) undergoing non-emergency (urgent or scheduled) cardiac surgery using cardiopulmonary bypass (CABG or combined CABG/valve).
- Patients must be able to understand English and be willing to sign informed consent.
You may not qualify if…
- Emergency surgery
- Off-pump coronary bypass grafting
- Aortic aneurysm repair
- Congenital heart disease repair
- Heart transplant or left ventricular assist device patient
- Severe heart failure (left ventricular ejection fraction <25%)
- Hemodynamic instability or requiring preoperative vasopressors or IABP
- Pre-existing kidney disease (eGFR <30 mL/min/1.73 m2) or renal transplantation.
- Presence of major active infection (chronic or acute, eg, sepsis, HIV, pneumonia)
- Chronic liver disease/cirrhosis
- Participation in an additional trial at the time of surgery or anytime within 30d of surgery where intervention could potentially alter renal health (unless in the control arm)
Where it is running
- Hoag Memorial Hospital Presbyterian — Newport Beach, California, United States
- Johns Hopkins University — Baltimore, Maryland, United States
- WakeMed Health and Hospitals — Raleigh, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.